RECRUITING

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, particularly in those subgroups of patients who are usually not recruited in randomized clinical trials (pregnant women, elderly patients, disseminated cancer, severe renal insufficiency, patients with contraindications to anticoagulation therapy, extreme body weight, etc), with the purpose of decreasing mortality, frequency of thromboembolic recurrences as well as bleeding complications and arterial events. As an additional objective RIETE is also aimed to create predictive scores that help physicians to better identify patients with high risk of presenting some of these complications. The primary parameters recorded by the registry comprise details of each patient's clinical status, including any coexisting or underlying conditions, and the type, dose, duration and outcome (during the first 3 months of therapy) of antithrombotic treatment. Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.

Official Title

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

Quick Facts

Study Start:2001-03
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02832245

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Confirmed VTE (acute deep-vein thrombosis, pulmonary embolism and/or superficial venous thrombosis) by objective tests.
  2. * Informed consent to the participation in the study, according to the requirements of the ethics committee within each hospital.
  1. * Participation in a therapeutic clinical trial with an unknown drug.
  2. * Inability to the 3 month follow-up

Contacts and Locations

Study Contact

Mayra Hawkins
CONTACT
0034915357183
riete@shmedical.es

Principal Investigator

Manuel Monreal
STUDY_CHAIR
Foundation for the study of VTE diseases. (FUENTE)

Study Locations (Sites)

Yale University School of Medicine
New Haven, Connecticut, 06510
United States
College of Medicine - Jacksonville University of Florida
Jacksonville, Florida, 32209
United States
Evanston NorthShore University HealthSystem
Evanston, Illinois, 60201
United States
Massachusetts General Hospital
Boston, Massachusetts, 02114
United States
Northwell Health System
Manhasset, New York, 11021
United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Manuel Monreal

  • Manuel Monreal, STUDY_CHAIR, Foundation for the study of VTE diseases. (FUENTE)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2001-03
Study Completion Date2027-12

Study Record Updates

Study Start Date2001-03
Study Completion Date2027-12

Terms related to this study

Additional Relevant MeSH Terms

  • Venous Thromboembolism